KCT0001861已完成未知
A Randomized, Open-label, Two-way Crossover, Single-Dose Clinical Trial to Compare Pharmacokinetic/Pharmacodynamic Properties and Safety after Subcutaneous Administration of Leucostim® and Neupogen® in Healthy Adult Volunteers
Dong-A ST0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 45(Year)（—）
- 性别
- Male
入选标准
- •1. Age 19 - 45 years
- •2. Body mass index(BMI) 18.5kg/m2 or greater but less than 25.0kg/m2
- •3. Value of ANC(absolute neutrophil count) had to be inside the normality range at the screening
排除标准
- •1. Subjects with a history or presence of clinically relevant hypersensitivity reaction to investigational drugs (G-CSF) or their ingredients/additives
- •2. Subjects with a clinically relevant history of allergic reaction
- •3. Subjects with a history of acute infectious diseases within 2 weeks prior to administration of investigational products
- •4. At the investigator's discretion, subjects who is considered inappropriate to participate in the study due to any conditions including screening results
研究者
相似试验
已完成
不适用
An Open-Label, Randomized, Two-Way Crossover, Multiple Dose, Comparative Bioavailability study of Aripiprazole ER IS (400 mg) in patients with schizophrenia.CTRI/2022/06/043537Apotex Inc58
尚未招募
不适用
A Randomized, Open-Label, Single-Center, Crossover Study of the Potential Effects of Paroxetine on the Pharmacokinetics of a Single Dose of Paliperidone Extended-Release in Healthy MeHealthy Volunteers10039628NL-OMON29906Janssen-Cilag60
进行中（未招募）
不适用
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients with Type 2 Diabetes and also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients with Different Degrees of PEIMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 DiabetesEUCTR2014-003511-11-SKAstraZeneca AB300
进行中（未招募）
不适用
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients with Type 2 Diabetes and also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients with Different Degrees of PEIMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 DiabetesEUCTR2014-003511-11-SEAstraZeneca AB300
进行中（未招募）
不适用
A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients with Type 2 Diabetes and also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients with Different Degrees of PEIType 2 DiabetesEUCTR2014-003511-11-HUAstraZeneca AB300